Oral insulin delivery: utopia, currently possible or a near reality?

Author:

Pinelo Rute1,Roque Luís2ORCID,Reis Catarina Pinto23ORCID

Affiliation:

1. Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa 1649003, Portugal

2. iMED.ULisboa (Research Institute for Medicines), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa 1649003, Portugal

3. IBEB (Biophysics & Biomedical Engineering), Faculty of Sciences, Universidade de Lisboa, Campo Grande, Lisboa 1749016, Portugal

Abstract

Diabetes is still one of the main diseases worldwide due to its high incidence, prevalence and, unfortunately, very high mortality. Type 1 diabetes (and in some other types) is generally controlled by exogenous insulin. Several attempts of oral insulin administration to humans have been done so far. Some of them achieved interesting results, but it seems to exist a barrier to transpose these studies into clinical trials. A broad perspective about the oral insulin and approaches will be addressed. Representative (not all) examples of innovation are herein described, and they should represent a step forward to achieve the main goal: to orally deliver insulin and improve the life quality of millions of patients.

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Reference78 articles.

1. RECENT ADVANCES AND FUTURE PROSPECTS OF NON-INVASIVE INSULIN DELIVERY SYSTEMS

2. Insulin delivery methods: Past, present and future

3. Food and Drug Administration (FDA). Afrezza® (insulin human) inhalation powder. www.accessdata.fda.gov/drugsatfda_docs/nda/2014/022472Orig1s000TOC.cfm

4. Insulinoterapia — nowe kierunki poszukiwań

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3